Literature DB >> 3538484

Lung function changes after allogenic bone marrow transplantation.

H Link, U Reinhard, M Blaurock, P Ostendorf.   

Abstract

The lung function of 21 patients with leukaemia (11 with acute myeloid leukaemia, six with acute lymphatic leukaemia, four with chronic myeloid leukaemia) and of five with severe aplastic anaemia was tested before and after allogenic bone marrow transplantation. Vital capacity (VC) was lowered in patients with leukaemia before transplantation. VC and FEV1 fell significantly after transplantation. Residual volume (RV) and RV as a percentage of total lung capacity (RV % TLC) were already increased and rose significantly after transplantation. Patients with severe aplastic anaemia had noticeably increased RV and RV % TLC, values that did not change after transplantation. In contrast to the patients with aplastic anaemia, the patients with leukaemia had significantly reduced VC, RV, RV % TLC, and FEV1 before and after transplantation. The specific airway resistance (sRaw) was raised significantly before and after transplantation in the leukaemic patients. In addition, transfer coefficient (Kco) fell significantly more after transplantation in the patients with leukaemia than in those with severe aplastic anaemia. In three patients with histologically established obstructive bronchiolitis in conjunction with chronic graft versus host disease after transplantation, VC, FEV1 and FEV1 % VC fell, while RV, RV % TLC, and sRaw rose; Kco was far below normal. On the basis of these findings it is concluded that in patients with leukaemia obstructive disorders of ventilation develop or, if they are already present, worsen. In patients with severe aplastic anaemia lung function was not impaired in the early phase after transplantation. These differences are probably due to the more intensive immunosuppressive and cytotoxic preparatory regimen before transplantation in the leukaemic patients. Obstructive bronchiolitis, a complication of graft versus host disease, first manifests itself in a typical rise in specific airway resistance and must be treated early.

Entities:  

Mesh:

Year:  1986        PMID: 3538484      PMCID: PMC460382          DOI: 10.1136/thx.41.7.508

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  16 in total

1.  [Critical selection of normal values for a computer program in the evaluation of lung function (author's transl)].

Authors:  K H Rühle; H Matthys
Journal:  Pneumonologie       Date:  1976-06-25

2.  Bronchiolitis obliterans after bone marrow transplantation.

Authors:  M E Rosenberg; G M Vercellotti; D C Snover; D Hurd; P McGlave
Journal:  Am J Hematol       Date:  1985-03       Impact factor: 10.047

Review 3.  Infectious complications of bone marrow transplantation.

Authors:  D J Winston; W G Ho; R E Champlin; R P Gale
Journal:  Exp Hematol       Date:  1984-03       Impact factor: 3.084

4.  Effect of anti-T-cell globulin on GVHD in leukemic patients treated with BMT.

Authors:  H Rodt; H J Kolb; B Netzel; R J Haas; K Wilms; C B Götze; H Link; S Thierfelder
Journal:  Transplant Proc       Date:  1981-03       Impact factor: 1.066

5.  Obstructive lung disease after allogeneic bone marrow transplantation.

Authors:  R Kurzrock; A Zander; M Kanojia; L Vellekoop; G Spitzer; S Jagannath; S Schell; L Peters; K Dicke
Journal:  Transplantation       Date:  1984-02       Impact factor: 4.939

6.  Reduced lung function in leukaemia patients undergoing bone marrow transplantation.

Authors:  P G Sørensen; P Ernst; J Panduro; J Møller
Journal:  Scand J Haematol       Date:  1984-03

7.  Pulmonary function in patients undergoing bone marrow transplantation.

Authors:  F T Serota; C S August; P A Koch; W Fox; G J D'Angio
Journal:  Med Pediatr Oncol       Date:  1984

8.  Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression.

Authors:  K M Sullivan; H M Shulman; R Storb; P L Weiden; R P Witherspoon; G B McDonald; M M Schubert; K Atkinson; E D Thomas
Journal:  Blood       Date:  1981-02       Impact factor: 22.113

9.  Bone marrow transplantation for acute myelogenous leukemia. Factors associated with early mortality.

Authors:  M M Bortin; R P Gale; H E Kay; A A Rimm
Journal:  JAMA       Date:  1983-03-04       Impact factor: 56.272

10.  Lung function after bone marrow grafting.

Authors:  M H Depledge; A Barrett; R L Powles
Journal:  Int J Radiat Oncol Biol Phys       Date:  1983-02       Impact factor: 7.038

View more
  4 in total

1.  Reduced-intensity hematopoietic stem cell transplantation for a patient with myelodysplastic syndrome and chronic obstructive pulmonary disease.

Authors:  Kosuke Obama; Tetsuya Eto; Nobuko Tsuruta; Yuko Nagara; Aki Okeda; Koji Kato; Tsuyoshi Muta; Hisashi Gondo; Tsunefumi Shibuya
Journal:  Int J Hematol       Date:  2004-12       Impact factor: 2.490

2.  Pulmonary function after bone marrow transplantation for chronic myeloid leukaemia.

Authors:  T G Sutedja; J F Apperley; J M Hughes; V R Aber; H G Kennedy; P Nunn; L Jones; L Hopper; J M Goldman
Journal:  Thorax       Date:  1988-03       Impact factor: 9.139

3.  Evaluation of respiratory conditions in early phase of hematopoietic stem cell transplantation.

Authors:  Eliane Aparecida Bom; Clarissa Vasconcelos de Souza; Rosana Almeida da Silva Thiesen; Eliana Cristina Martins Miranda; Carmino Antonio de Souza
Journal:  Rev Bras Hematol Hemoter       Date:  2012

4.  Can lung function measurements be used to predict which patients will be at risk of developing interstitial pneumonitis after bone marrow transplantation?

Authors:  H J Milburn; H G Prentice; R M du Bois
Journal:  Thorax       Date:  1992-06       Impact factor: 9.139

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.